Government purchases more COVID treatments from Lilly
INDIANAPOLIS (Inside INdiana Business) -- Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. government has made another purchase of 614,000 doses of the combination bamlanivimab and etesevimab antibody therapy for COVID-19. As part of the nearly $1.3 billion purchase, Lilly says it will deliver the doses no later than January 31.